Debt to EBITDA ratio Analysis of AcelRx Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of ACRX
Dec-230Excellent Debt to EBITDA | Dec-220.148Excellent Debt to EBITDA | Growth0% |
Debt to EBITDA Analysis of AcelRx Pharmaceuticals Inc
| Debt to EBITDA Ratio of ACRX has fallen by 0 % Compared to previous Financial Year. |
| Debt to EBITDA Ratio with value of 0.148 was highest in Year Dec-22 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.653 was lowest in Year Dec-20 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of 0 is Greater than Average Debt to EBITDA of -0.301 in last five years. |
Other Debt to EBITDA Related Info of ACRX that may interest you.
AcelRx Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ACRX | 0.8945 | 0.86 | 4.01 % | Drug Manufacturers-Specialty & Generic |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Good Stability | |
FY - Historical Debt to EBITDA of AcelRx Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | 0 | 0.148 | -0.482 | -0.653 | -0.518 | -0.353 | -0.524 |
| Change | 0 % | 130.60 % | 26.12 % | -25.92 % | -47.08 % | 32.75 % | 29.48 % |
FY Chart of Debt to EBITDA of AcelRx Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)